A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.

Preclinical data with the investigational gene therapy INS1202 show improvements in survival and motor performance in ALS.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

Only recently has the ribosome - one of the oldest molecular machines in evolutionary terms - been recognized as an active regulator of gene expression at the level of protein biosynthesis.

Long before mRNA vaccines captured global attention during the COVID-19 pandemic, researchers were already exploring their ...

Only recently has the ribosome—one of the oldest molecular machines in evolutionary terms—been recognized as an active ...

We recently published a list of 10 Worst High-Risk High-Reward Growth Stocks To Buy. In this article, we are going to take a ...

Total company revenue fell from a peak of $19.3 billion in 2022 to $3.2 billion for the full year ended Dec. 31, 2024. For ...

Alternative splicing (AS) of pre-mRNA plays a crucial role in tissue-specific gene regulation, with disease implications due to splicing defects. Predicting and manipulating AS can therefore uncover ...

RNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.